Population Pharmacokinetic Modeling of Sertraline Treatment in Patients With Alzheimer Disease: The DIADS-2 Study

Li, Claire H. BS
Pollock, Bruce G. MD, PhD
Lyketsos, Constantine G. MD, MHS
Vaidya, Vijay MPH, MS
Drye, Lea T. PhD
Kirshner, Margaret BA
Sorisio, Denise BS
Bies, Robert R. PharmD, PhD

¹ Indiana University School of Medicine, Indianapolis, IN, USA
² Indiana Clinical and Translational Sciences Institute (CTSI), Indianapolis, IN, USA
³ Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada
⁴ School of Medicine, Johns Hopkins University, Baltimore, MD, USA
⁵ School of Public Health, Johns Hopkins University Bloomberg, Baltimore, MD, USA
⁶ University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Submitted for publication 29 November 2011; accepted 7 March 2012

Corresponding Author:

Claire H. Li, BS, Division of Clinical Pharmacology, Indiana University School of Medicine, and Indiana Clinical and Translational Sciences Institute (CTSI), Wishard Memorial Hospital, 1001 West 10th Street, WD Meyers Building, W7123, Indianapolis, IN 46202, USA Email: [email protected]

^*Members of this group are listed in the note at the end of the article.

The Journal of Clinical Pharmacology 53(2):p 234-239, February 2013. | DOI: 10.1177/0091270012445793